Literature DB >> 17406989

Incidence of esophageal and gastric cancers among Hispanics, non-Hispanic whites and non-Hispanic blacks in the United States: subsite and histology differences.

Xiaocheng Wu1, Vivien W Chen, Patricia A Andrews, Bernardo Ruiz, Pelayo Correa.   

Abstract

OBJECTIVE: We examined subsite- and histology-specific esophageal and gastric cancer incidence patterns among Hispanics/Latinos and compared them with non-Hispanic whites and non-Hispanic blacks.
METHODS: Data on newly diagnosed esophageal and gastric cancers for 1998-2002 were obtained from 37 population-based central cancer registries, representing 66% of the Hispanic population in the United States. Age-adjusted incidence rates (2000 US) were computed by race/ethnicity, sex, anatomic subsite, and histology. The differences in incidence rates between Hispanics and non-Hispanics were examined using the two-tailed z-statistic.
RESULTS: Squamous cell carcinoma accounted for 50% and 57% of esophageal cancers among Hispanic men and women, respectively, while adenocarcinoma accounted for 43% among Hispanic men and 35% among Hispanic women. The incidence rate of squamous cell carcinoma was 48% higher among Hispanic men (2.94 per 100,000) than non-Hispanic white men (1.99 per 100,000) but about 70% lower among Hispanics than non-Hispanic blacks, for both men and women. In contrast, the incidence rates of esophageal adenocarcinoma were lower among Hispanics than non-Hispanic whites (58% lower for men and 33% for women) but higher than non-Hispanic blacks (70% higher for men and 64% for women). Cardia adenocarcinoma accounted for 10-15% of gastric cancers among Hispanics, and the incidence rate among Hispanic men (2.42 per 100,000) was 33% lower than the rate of non-Hispanic white men (3.62 per 100,000) but 37% higher than that of non-Hispanic black men. The rate among Hispanic women (0.86 per 100,000), however, was 20% higher than that of non-Hispanic white women (0.72 per 100,000) and 51% higher than for non-Hispanic black women. Gastric non-cardia cancer accounted for approximately 50% of gastric cancers among Hispanics (8.32 per 100,000 for men and 4.90 per 100,000 for women), and the rates were almost two times higher than for non-Hispanic whites (2.95 per 100,000 for men and 1.72 per 100,000 for women) but about the same as the non-Hispanic blacks.
CONCLUSION: Subsite- and histology-specific incidence rates of esophageal and gastric cancers among Hispanics/Latinos differ from non-Hispanics. The incidence rates of gastric non-cardia cancer are almost two times higher among Hispanics than non-Hispanic whites, both men and women. The rates of gastric cardia cancer are lower among Hispanics than non-Hispanic whites for men but higher for women. The rates of esophageal and gastric cardia adenocarcinomas are higher among Hispanics than non-Hispanic blacks.

Entities:  

Mesh:

Year:  2007        PMID: 17406989     DOI: 10.1007/s10552-007-9000-1

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  32 in total

1.  Trends in Major Gastrectomy for Cancer: Frequency and Outcomes.

Authors:  Eric M Groh; Noorie Hyun; David Check; Theo Heller; R Taylor Ripley; Jonathan M Hernandez; Barry I Graubard; Jeremy L Davis
Journal:  J Gastrointest Surg       Date:  2018-12-03       Impact factor: 3.452

2.  Reduced Risk of Barrett's Esophagus in Statin Users: Case-Control Study and Meta-Analysis.

Authors:  Ian L P Beales; Leanne Dearman; Inna Vardi; Yoon Loke
Journal:  Dig Dis Sci       Date:  2015-09-19       Impact factor: 3.199

3.  Can a gastric cancer risk survey identify high-risk patients for endoscopic screening? A pilot study.

Authors:  Haejin In; Marisa Langdon-Embry; Lauren Gordon; Clyde B Schechter; Judith Wylie-Rosett; Philip E Castle; M Margaret Kemeny; Bruce D Rapkin
Journal:  J Surg Res       Date:  2018-04-03       Impact factor: 2.192

4.  Hyperactivity of the transcription factor Nrf2 causes metabolic reprogramming in mouse esophagus.

Authors:  Junsheng Fu; Zhaohui Xiong; Caizhi Huang; Jing Li; Wenjun Yang; Yuning Han; Chorlada Paiboonrungruan; Michael B Major; Ke-Neng Chen; Xiaozheng Kang; Xiaoxin Chen
Journal:  J Biol Chem       Date:  2018-11-08       Impact factor: 5.157

5.  Epidermal growth factor A61G gene polymorphism, gastroesophageal reflux disease and esophageal adenocarcinoma risk.

Authors:  Winson Y Cheung; Rihong Zhai; Matthew H Kulke; Rebecca S Heist; Kofi Asomaning; Clement Ma; Zhaoxi Wang; Li Su; Michael Lanuti; Kenneth K Tanabe; David C Christiani; Geoffrey Liu
Journal:  Carcinogenesis       Date:  2009-06-11       Impact factor: 4.944

Review 6.  Pathology of gastric intestinal metaplasia: clinical implications.

Authors:  Pelayo Correa; M Blanca Piazuelo; Keith T Wilson
Journal:  Am J Gastroenterol       Date:  2010-03       Impact factor: 10.864

7.  Obesity and late-age survival without major disease or disability in older women.

Authors:  Eileen Rillamas-Sun; Andrea Z LaCroix; Molly E Waring; Candyce H Kroenke; Michael J LaMonte; Mara Z Vitolins; Rebecca Seguin; Christina L Bell; Margery Gass; Todd M Manini; Kamal H Masaki; Robert B Wallace
Journal:  JAMA Intern Med       Date:  2014-01       Impact factor: 21.873

8.  Targeting chemokine pathways in esophageal adenocarcinoma.

Authors:  Makardhwaj S Shrivastava; Zulfiqar Hussain; Orsolya Giricz; Niraj Shenoy; Rahul Polineni; Anirban Maitra; Amit Verma
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

9.  An Investigation into the Recent Increase in Gastric Cancer in the USA.

Authors:  Maya Balakrishnan; Rollin George; Ashish Sharma; David Y Graham; Hoda M Malaty
Journal:  Dig Dis Sci       Date:  2018-03-15       Impact factor: 3.199

10.  Oesophageal cancer incidence in the United States by race, sex, and histologic type, 1977-2005.

Authors:  M B Cook; W-H Chow; S S Devesa
Journal:  Br J Cancer       Date:  2009-08-11       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.